3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
6
Gastrointestinal
4
Lymphoid
1
Conditions
Lymphoproliferative Disorders
1
Anemia, Iron-Deficiency
1
Anemia
1
Interventions
Cyclophosphamide
27
Vincristine
24
Dexamethasone
22
Rituximab
21
Methotrexate
21
Cytarabine
21
Mercaptopurine
16
Doxorubicin
15
Etoposide
13
Asparaginase
13
Daunorubicin
12
Prednisone
10
Prednisolone
10
Granulocyte Colony-Stimulating Factor
10
Ifosfamide
8
Idarubicin
8
fludarabine
7
pegylated granulocyte colony-stimulating factor
6
Thioguanine
6
Teniposide
6
Vindesine
5
Brentuximab Vedotin
5
ibrutinib
4
fludarabine phosphate
4
Stem Cell Transplantation
4
Gemcitabine
4
Cisplatin
4
Aprepitant
4
zanubrutinib
3
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
ferric carboxymaltose
×
Lymphoid
×
Clear all
NCT01100879
2022-05-09
AOC-MM
Vifor Pharma
Phase 4
Terminated
3 enrolled